ESG risk score 20.1
Environmental score 3.34
Social score 10.55
Governance score 6.22
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
ResMed Inc.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol RMD:xnys
Currency USD
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -2.13%
1 year -6.26%
3 years 64.37%
Data provided by 
Key stats
Price/earnings (LTM) 21.47
Dividend yield (LTM) 1.04%
EPS (LTM) 10.98
Volatility (30 days) 44.91%
Data provided by
Analyst consensus
Average rating Overweight
Rating Analysts
Buy
12
Overweight
5
Hold
10
Underweight
2
Sell
1
Target price 272.76
Implied return 15.7%
Last updated 30-Oct-2026
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About ResMed Inc.
ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
Sector Healthcare
Industry -
Market cap 33bn
Data provided by /
/ Frequently asked questions
To buy ResMed Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ResMed Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ResMed Inc. is RMD. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ResMed Inc. has its primary listing on New York Stock Exchange. You can trade ResMed Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ResMed Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include ResMed Inc. as part of a broader investment portfolio.